| NanoBRET: the bright future of proximity-based assays NC Dale, EKM Johnstone, CW White, KDG Pfleger Frontiers in bioengineering and biotechnology 7, 56, 2019 | 152 | 2019 |
| Orexin signaling: a complex, multifaceted process NC Dale, D Hoyer, LH Jacobson, KDG Pfleger, EKM Johnstone Frontiers in Cellular Neuroscience 16, 812359, 2022 | 27 | 2022 |
| GPCR heteromers: An overview of their classification, function and physiological relevance NC Dale, EKM Johnstone, KDG Pfleger Frontiers in Endocrinology 13, 931573, 2022 | 18 | 2022 |
| CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans CW White, S Platt, LE Kilpatrick, N Dale, RS Abhayawardana, S Dekkers, ... Science signaling 17 (828), eabl3758, 2024 | 2 | 2024 |
| Bioluminescence Resonance Energy Transfer (BRET) Technologies to Study GPCRs NC Dale, CW White, EKM Johnstone, KDG Pfleger GPCRs as Therapeutic Targets 2, 841-873, 2022 | 2 | 2022 |
| CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action CW White, LE Kilpatrick, N Dale, RS Abhayawardana, S Dekkers, ... bioRxiv, 2021.07. 05.451109, 2021 | 2 | 2021 |
| Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists SA Cullum, S Platt, N Dale, OC Isaac, ES Wragg, M Soave, DB Veprintsev, ... Communications Biology 7 (1), 417, 2024 | | 2024 |
| An in-depth investigation of orexin receptor pharmacology profiled using advanced Bioluminescence Resonance Energy Transfer (BRET) techniques N Dale | | 2022 |
| The orexins exhibit distinct pharmacological profiles at orexin receptor 2 N Dale, E Johnstone, K Pfleger BRITISH JOURNAL OF PHARMACOLOGY 178 (2), 434-435, 2021 | | 2021 |
